Stoke Therapeutics STOK Earnings Call Transcripts

NASDAQ STOK
$27.21 -0.50 (-1.80%)
At close: Nov 10, 2026 · 4:00 PM EST
2 earnings calls on file for Stoke Therapeutics, from Q2 2026 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Stoke Therapeutics Q3 2026 Earnings Call

Oct 29, 2026 8,877 words · 39 min read
  • Thomas LeggettChief Financial Officer
  • Ian SmithChief Executive Officer
  • Dr. Barry TichoChief Medical Officer
  • Jason HoittChief Patient Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Stoke Therapeutics Earnings Call Transcripts

Calls2
LatestOct 29, 2026
SinceQ2 2026

Fiscal 2026

All 2 Stoke Therapeutics transcripts Register to get access to Stoke Therapeutics’s earnings call transcripts.